Literature DB >> 1882385

Glucocorticoid-induced central diabetes insipidus in a case of malignant lymphoma.

M Ohta1, T Kimura, K Ota, M Shoji, M Inoue, K Sato, T Yamamoto, K Endo, M Narita, K Abe.   

Abstract

A 37-year-old man was diagnosed as malignant lymphoma infiltrating in the central nervous system with hypopituitrism and secondary glucocorticoid deficiency. In this case, plasma arginine vasopressin (AVP) increased, but glucocorticoid administration decreased plasma AVP and increased urine volume with a reduction in urinary osmolality, indicative of the presence of glucocorticoid-induced diabetes insipidus. At the terminal stage, plasma AVP did not increase in response to the withdrawal of glucocorticoid and urine volume remained decreased, suggesting the presence of masked diabetes insipidus. Autopsy showed an infiltration of lymphoid cells around the cerebral ventricles and necrosis in the hypothalamo-hypophyseal system. These findings suggested that glucocorticoid might centrally play an important role in the regulation of AVP release, and its deficiency potentiated AVP release.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882385     DOI: 10.1620/tjem.163.245

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Competing interests in a lung cancer with metastasis to the pituitary gland: syndrome of inappropriate ADH secretion versus diabetes insipidus.

Authors:  Gaurav Singh Gulsin; Madeleine Louisa Bryson Jacobs; Shailesh Gohil; Adam Thomas; Miles Levy
Journal:  Oxf Med Case Reports       Date:  2016-06-01

Review 2.  Central diabetes insipidus unveiled by glucocorticoid therapy in a patient with an empty sella: A case report and literature review.

Authors:  Lei-Yi Yang; Sang Lin; Qi-Bing Xie; Geng Yin
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.